Analysis published in ASN, highlighted compelling evidence that ERAs offer substantial therapeutic benefits for CKD patients.

FDA requests removal of suicidal ideation warnings from GLP-1 RA labels after meta-analysis shows no increased risk compared with placebo.

More representative trial populations and standardized subgroup reporting are needed in non–small cell lung cancer (NSCLC) research, according to a meta-analysis published in Cancers, which found no ...

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...

A comprehensive meta-analysis of 18 studies, involving more than 1 million patients with autoimmune diseases, has revealed a 36% higher risk of central nervous system (CNS) inflammatory diseases in ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing that beef can be enjoyed in a heart-healthy diet. Specifically, research ...

ImmunoCheckDB consists of three main functional modules: meta-analysis, network meta-analysis, and multiomics association analysis. The data collection, data overview, and specific applications of the ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. A sweeping meta-analysis of over 10,000 studies has found that ...